» Authors » Hanna Rennert

Hanna Rennert

Explore the profile of Hanna Rennert including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 76
Citations 1459
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sattar U, Yin X, Luo X, Zhu C, Hu Z, Blumenfeld J, et al.
AJNR Am J Neuroradiol . 2024 Jul; 46(1):200-206. PMID: 38991774
Background And Purpose: Patients with autosomal dominant polycystic kidney disease (ADPKD) develop cysts in the kidneys, liver, spleen, pancreas, prostate, and arachnoid spaces. In addition, spinal meningeal diverticula have been...
2.
Hu Z, Sharbatdaran A, He X, Zhu C, Blumenfeld J, Rennert H, et al.
Sci Rep . 2024 Jun; 14(1):13794. PMID: 38877066
Mayo Imaging Classification (MIC) for predicting future kidney growth in autosomal dominant polycystic kidney disease (ADPKD) patients is calculated from a single MRI/CT scan assuming exponential kidney volume growth and...
3.
Solomon J, Munoz-Zuluaga C, Slocum C, Dillard A, Cong L, Wang J, et al.
Diagn Pathol . 2024 May; 19(1):70. PMID: 38796421
IDH1 and IDH2 mutational status is a critical biomarker with diagnostic, prognostic, and treatment implications in glioma. Although IDH1 p.R132H-specific immunohistochemistry is available, it is unable to identify other mutations...
4.
Schumacher K, Prince M, Blumenfeld J, Rennert H, Hu Z, Dev H, et al.
Abdom Radiol (NY) . 2024 Mar; 49(7):2285-2295. PMID: 38530430
Background And Purpose: The objective is to demonstrate feasibility of quantitative susceptibility mapping (QSM) in autosomal dominant polycystic kidney disease (ADPKD) patients and to compare imaging findings with traditional T1/T2w...
5.
Velu P, Sipley J, Marino J, Ghanshani S, Lukose G, Cong L, et al.
J Mol Diagn . 2023 Jul; 25(10):740-747. PMID: 37474002
An epidemic caused by an outbreak of mpox (formerly monkeypox) in May 2022 rapidly spread internationally, requiring an urgent response from the clinical diagnostics community. A detailed description of the...
6.
Liu J, Yin X, Dev H, Luo X, Blumenfeld J, Rennert H, et al.
J Clin Med . 2023 Jan; 12(1). PMID: 36615184
Autosomal dominant polycystic kidney disease (ADPKD) has cystic fluid accumulations in the kidneys, liver, pancreas, arachnoid spaces as well as non-cystic fluid accumulations including pericardial effusions, dural ectasia and free...
7.
Velu P, Cong L, Rand S, Qiu Y, Zhang Z, Zhang J, et al.
Diagn Microbiol Infect Dis . 2022 Sep; 104(4):115789. PMID: 36122486
We evaluated the performance of SARS-CoV-2 TaqMan real-time reverse-transcription PCR (RT-qPCR) assays (ThermoFisher) for detecting 2 nonsynonymous spike protein mutations, E484K and N501Y. Assay accuracy was evaluated by whole genome...
8.
Zhang Z, Blumenfeld J, Ramnauth A, Barash I, Zhou P, Levine D, et al.
Clin Genet . 2022 Aug; 102(6):483-493. PMID: 36029107
Autosomal dominant polycystic kidney disease (ADPKD), caused by mutations in PKD1 and PKD2 (PKD1/2), has unexplained phenotypic variability likely affected by environmental and other genetic factors. Approximately 10% of individuals...
9.
Goel A, Shih G, Riyahi S, Jeph S, Dev H, Hu R, et al.
Radiol Artif Intell . 2022 Apr; 4(2):e210205. PMID: 35391774
This study develops, validates, and deploys deep learning for automated total kidney volume (TKV) measurement (a marker of disease severity) on T2-weighted MRI studies of autosomal dominant polycystic kidney disease...
10.
Park J, Foox J, Hether T, Danko D, Warren S, Kim Y, et al.
Cell Rep Med . 2022 Mar; 3(2):100522. PMID: 35233546
The molecular mechanisms underlying the clinical manifestations of coronavirus disease 2019 (COVID-19), and what distinguishes them from common seasonal influenza virus and other lung injury states such as acute respiratory...